Mazor Robotics (NSDQ:MZOR) today reported third-quarter results that blew past the consensus forecast on Wall Street, more than doubling sales and paring its losses by more than 30%. The Caesarea, Israel-based robot-assisted surgery company posted losses of -$3.7 million, or -7¢ per share, on sales of $17.2 million for the three months ended Sept. 30, cutting…
Mazor Robotics ticks up on Q3 prelims
Mazor Robotics (NSDQ:MZOR) shares ticked up today after the Israeli robot-assisted surgery company reported its preliminary sales numbers for the third quarter. Caesarea, Israel-based Mazor, which last month closed a third, $40 million tranche as part of its deal with Medtronic (NYSE:MDT), said it expects to post sales of $17.2 million for the 3 months ended…
Mazor X surgery platform from Mazor Robotics wins CE Mark
Mazor Robotics (NSDQ:MZOR) said today that it won CE Mark approval in the European Union for its Mazor X robot-assisted surgery platform, setting the stage for strategic backer Medtronic (NYSE:MDT) to put the device on the European market. “Receipt of the CE Mark is an important step in our plan to expand the patient, surgeon and hospital benefits…
Medtronic, Mazor Robotics close $40m round
Mazor Robotics (NSDQ:MZOR) said today that closed the third, $40 million tranche of a deal with Medtronic (NYSE:MDT), which is due to take on exclusive global distribution rights for the Mazor X robot-assisted surgery device. It’s the third investment in the Israeli surgical robotics concern for Fridley, Minn.-based Medtronic, taking its total investment to $72 million, 10.6% stake in…
Medtronic puts another $40m into Mazor Robotics
Mazor Robotics (NSDQ:MZOR) said today that it’s accelerating a deal with Medtronic (NYSE:MDT), which is due to put another $40 million into Mazor and take on exclusive global distribution rights for the Mazor X robot-assisted surgery device. It’s the third investment in the Israeli surgical robotics concern for Fridley, Minn.-based Medtronic, taking its total investment to $72 million and…
Mazor Robotics gets a boost from Q2 prelims
Shares in Mazor Robotics (NSDQ:MZOR) got a boost today as investors reacted to its forecast for record second-quarter sales. Caesarea, Israel-based Mazor said it expects to post revenues of roughly $15.4 million for the 3 months ended June 30, which would be a 85.5% increase over the same period last year and 24.6% above the consensus…
Mazor Robotics reveals Israeli regulatory probe
Mazor Robotics (NSDQ:MZOR) yesterday revealed a probe by Israel’s version of the U.S. Securities & Exchange Commission, sending share prices down today in early trading. Caesarea, Israel-based Mazor said the Israeli Securities Authority searched its offices and questioned some members of management in May, “in connection with an investigation held by the ISA.” “Mazor has not been informed…
Robotic surgery: Here’s everything you need to know
[<a href=”//storify.com/MedTechDaily/getting-started” target=”_blank”>View the story “Robotic surgery: Here’s everything you need to know” on Storify</a>]
FDA clears Mazor X Align spinal surgical planning software
Mazor Robotics (NSDQ:MZOR) said today it won FDA clearance for its Mazor X Align spinal surgical planning software, with plans to launch in early May. The Mazor X Align software is designed to assist surgeons in planning for spinal deformity correction and spinal alignment procedures with the Mazor X Surgical Assurance platform, the Israel-based company said.…
Mazor Robotics slides on Q1 prelims
Share prices for Mazor Robotics (NSDQ:MZOR) slid today despite preliminary 1st-quarter sales numbers that beat expectations on Wall Street. The Caesarea, Israel-based robot-assisted surgery device maker said it expects to post sales of $11.5 million for the 3 months ended March 31, ahead of The Street’s $11.2 million forecast and up 79.7% compared with Q1 2016. Investors…
Mazor Robotics dips despite Street-beating Q4, 2016
Mazor Robotics (NSDQ:MZOR) shares are down this morning despite the company’s report that both 4th-quarter and full-year results topped expectations on Wall Street. The Caesarea, Israel-based robot-assisted surgery company posted widened losses of -$4.2 million, or -9¢ per share, on sales of $14.0 million for the 3 months ended Dec. 31. That amounts to a 48.8% increase…
11 surgical robotics companies you need to know
Robotic surgery is taking off, and the field is becoming increasingly diverse. We’ve collected information on the biggest players in the field so far. Intuitive Surgical’s da Vinci robot remains the premier surgical robotics company, with other companies including Stryker and Zimmer-Biomet only getting into the field in recent years. Read on to find out more.…
Mazor Robotics gains on Street-beating Q4 outlook
Mazor Robotics (NSDQ:MZOR) said today that it expects its 4th-quarter revenues to top expectations on Wall Street, sending share prices up in mid-day trading. The Caesarea, Israel-based robot-assisted surgery company said it expects to post sales of $14 million for the 3 months ended Dec. 31, 2016, ahead of the $12.9 million forecast on The Street,…